CLCN3 and colorectal cancer: In one study, after inhibiting the expression of CLC‐3, the expression of Wnt/β‐catenin signal pathway‐related proteins in SW480 and SW620 cells was decreased, indicating that CLC‐3 may be a potential treatment for colorectal cancer in the future.7